Short Interest in Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Declines By 79.6%

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) was the recipient of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 5,200 shares, a drop of 79.6% from the May 31st total of 25,500 shares. Based on an average daily volume of 53,100 shares, the short-interest ratio is presently 0.1 days.

Fresenius SE & Co. KGaA Price Performance

FSNUY stock traded up $0.01 during trading on Thursday, reaching $7.45. 35,035 shares of the company were exchanged, compared to its average volume of 46,277. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 1.54. The stock’s 50 day moving average price is $7.73 and its 200 day moving average price is $7.36. Fresenius SE & Co. KGaA has a 52-week low of $6.33 and a 52-week high of $8.44. The company has a market cap of $16.64 billion, a P/E ratio of 10.21 and a beta of 1.06.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) last announced its quarterly earnings results on Wednesday, May 8th. The company reported $0.20 EPS for the quarter. The business had revenue of $6.19 billion for the quarter. Fresenius SE & Co. KGaA had a return on equity of 4.88% and a net margin of 0.71%. As a group, analysts predict that Fresenius SE & Co. KGaA will post 0.81 earnings per share for the current fiscal year.

About Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.